GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) » Definitions » Operating Cash Flow per Share

Guangzhou Wondfo Biotech Co (SZSE:300482) Operating Cash Flow per Share : ¥1.48 (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Guangzhou Wondfo Biotech Co Operating Cash Flow per Share?

Guangzhou Wondfo Biotech Co's operating cash flow per share for the three months ended in Mar. 2024 was ¥0.25. Guangzhou Wondfo Biotech Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.48.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Guangzhou Wondfo Biotech Co was -64.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -32.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 18.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 23.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Guangzhou Wondfo Biotech Co's Operating Cash Flow per Share or its related term are showing as below:

SZSE:300482' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -32.5   Med: 16.1   Max: 80.9
Current: -32.5

During the past 13 years, Guangzhou Wondfo Biotech Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 80.90% per year. The lowest was -32.50% per year. And the median was 16.10% per year.

SZSE:300482's 3-Year OCF Growth Rate is ranked worse than
84.45% of 688 companies
in the Medical Devices & Instruments industry
Industry Median: 2.85 vs SZSE:300482: -32.50

Guangzhou Wondfo Biotech Co Operating Cash Flow per Share Historical Data

The historical data trend for Guangzhou Wondfo Biotech Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Wondfo Biotech Co Operating Cash Flow per Share Chart

Guangzhou Wondfo Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 2.41 1.50 3.81 0.74

Guangzhou Wondfo Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.50 0.29 0.13 0.80 0.25

Competitive Comparison of Guangzhou Wondfo Biotech Co's Operating Cash Flow per Share

For the Medical Devices subindustry, Guangzhou Wondfo Biotech Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Wondfo Biotech Co's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guangzhou Wondfo Biotech Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Guangzhou Wondfo Biotech Co's Price-to-Operating-Cash-Flow falls into.



Guangzhou Wondfo Biotech Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Guangzhou Wondfo Biotech Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=328.679/443.295
=0.74

Guangzhou Wondfo Biotech Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )=Cash Flow from Operations (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=113.225/445.580
=0.25

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangzhou Wondfo Biotech Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Guangzhou Wondfo Biotech Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangzhou Wondfo Biotech Co (SZSE:300482) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Lizhishan Road, Science City, Luogang District, Guangdong, Guangzhou, CHN, 510641
Guangzhou Wondfo Biotech Co Ltd manufactures medical diagnostic tests. Its products include immunodiagnostic rapid test kits, including fertility, which include pregnancy HCG, ovulation LH, and others. The company's products are used in a clinical test, field test, and personal health management, among others.
Executives
He Xiao Wei Director
Kang Ke Ren Executives
Yu Fang Xia Executives
Li Wen Mei Directors, executives
Wang Ji Hua Director
Peng Zhong Xiong Executives
Zhao Ya Ping Executives
Luo Hong Supervisors
Zhou Yong Supervisors

Guangzhou Wondfo Biotech Co (SZSE:300482) Headlines

No Headlines